Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Caris Life Sciences Inc (CAI)

Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Caris Life Sciences Inc 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 USA

www.carislifesciences.com P: 866-771-8946

Sector:

Medical

Description:

Caris Life Sciences Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring and precision medicine enabling aspects. Caris Life Sciences Inc. is based in Irving, TX.

Key Statistics

Overview:

Market Capitalization, $K 6,207,235
Enterprise Value, $K 6,207,235
Shares Outstanding, K 282,147
Float, K 260,140
% Float 92.20%
Short Interest, K 6,607
Short Float 2.34%
Days to Cover 2.37
Short Volume Ratio 0.52
% of Insider Shareholders 7.80%

Financials:

Annual Sales, $ 294,010 K
Annual Net Income, $ 27,730 K
Last Quarter Sales, $ 216,830 K
Last Quarter Net Income, $ 24,330 K
EBIT, $ -113,200 K
EBITDA, $ -113,200 K

Growth:

1-Year Return -21.43%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.08 on 11/05/25
Next Earnings Date 02/04/26
Earnings Per Share ttm -0.46
EPS Growth vs. Prev Qtr 114.81%
EPS Growth vs. Prev Year 675.60%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 09/09/21
Dividend Payable Date 09/27/21
Dividend Payout Ratio 0.00%

CAI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 65.72
Price/Earnings to Growth 1.69
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 9.43%
Debt/Equity 0.79
Price/Sales 9.56
Price/Cash Flow N/A
Price/Book 12.49
Book Value/Share 1.70
Interest Coverage 0.00
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar